North Carolina Health Center COVID-19 Survey Summary Report

Latest data from October 8, 2021

Number of Health Center respondents = 36 (92% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 20,222
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 47.13%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 2,012
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 42.05%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 45.22% 52.88%
White, Hispanic/Latino Patients 8.22% 8.40%
Black/African American, Non-Hispanic/Latino Patients 23.63% 19.73%
Black/African American, Hispanic/Latino Patients 0.42% 0.25%
Asian Patients3 0.68% 0.50%
American Indian/Alaska Native Patients3 1.11% 1.04%
Native Hawaiian/Other Pacific Islander Patients3 0.17% 0.15%
Patients with More than one race3 1.80% 2.14%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 4.27% 6.16%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.54% 1.64%
Unreported/Refused to Report Race and Ethnicity 12.93% 7.11%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 1,511
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 80.28%
COVID-19 Immunization Series Completed 2,082
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 76.56%
COVID-19 Immunization Series Additional 412
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 57.36%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 18.73% 22.00% 41.50%
White, Hispanic/Latino Patients 16.08% 15.56% 5.34%
Black/African American, Non-Hispanic/Latino Patients 34.48% 32.76% 37.38%
Black/African American, Hispanic/Latino Patients 0.53% 1.10% 0.24%
Asian Patients3 0.73% 0.34% 3.40%
American Indian/Alaska Native Patients3 1.65% 1.59% 4.61%
Native Hawaiian/Other Pacific Islander Patients3 0.66% 0.53% 0.49%
Patients with More than one race3 2.85% 3.70% 0.73%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 19.26% 16.28% 3.64%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 2.05% 2.11% 0.73%
Unreported/Refused to Report Race and Ethnicity 2.98% 4.03% 1.94%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 16.67%
1 to 24 Hours 11.11%
More Than 24 Hours 72.22%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 5.56%
Staffing to administer the vaccine 30.56%
Vaccine confidence 25.00%
Vaccine storage capacity 0.00%
Vaccine supply 0.00%
Other 8.33%
None 41.67%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 30.56%
Average Percent of Health Center Visits Conducted Virtually 15.56%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 27.78%
Number of Mobile Van Sites 17
Number of Pop-up Clinics 21
Number of School-Based Vaccination Sites 1

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 2.78%
Refer patients to another organization that provides monoclonal antibody therapies 50.00%
None 47.22%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 8.33%
Patient awareness/education 11.11%
Staffing capacity 22.22%
Therapy administration/onsite logistics 19.44%
Other 5.56%
None 52.78%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021